Anna E. Koopmans

1.1k total citations
15 papers, 805 citations indexed

About

Anna E. Koopmans is a scholar working on Ophthalmology, Oncology and Molecular Biology. According to data from OpenAlex, Anna E. Koopmans has authored 15 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Ophthalmology, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Anna E. Koopmans's work include Ocular Oncology and Treatments (11 papers), Immunotherapy and Immune Responses (4 papers) and Cutaneous Melanoma Detection and Management (4 papers). Anna E. Koopmans is often cited by papers focused on Ocular Oncology and Treatments (11 papers), Immunotherapy and Immune Responses (4 papers) and Cutaneous Melanoma Detection and Management (4 papers). Anna E. Koopmans collaborates with scholars based in Netherlands, United States and Gambia. Anna E. Koopmans's co-authors include Annelies de Klein, Jolanda Vaarwater, Dion Paridaens, Robert M. Verdijk, Emine Kılıç, Nicole C. Naus, Bert Eussen, Serdar Yavuzyiğitoğlu, Thierry van den Bosch and Rutger W. W. Brouwer and has published in prestigious journals such as Ophthalmology, British Journal of Cancer and PLoS Medicine.

In The Last Decade

Anna E. Koopmans

14 papers receiving 796 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna E. Koopmans Netherlands 11 504 281 261 219 111 15 805
Maartje J. Geerlings Netherlands 15 334 0.7× 36 0.1× 211 0.8× 171 0.8× 56 0.5× 21 567
Marina Gualco Italy 14 125 0.2× 335 1.2× 221 0.8× 354 1.6× 65 0.6× 26 697
Angela Douglas United Kingdom 8 226 0.4× 118 0.4× 135 0.5× 55 0.3× 22 0.2× 10 483
Martin Nguyen United States 13 72 0.1× 135 0.5× 272 1.0× 136 0.6× 26 0.2× 28 741
PJ van Diest Netherlands 4 58 0.1× 84 0.3× 235 0.9× 60 0.3× 36 0.3× 13 450
Andrea Pelosi Italy 18 49 0.1× 202 0.7× 489 1.9× 297 1.4× 43 0.4× 35 912
Benjamin L. George Singapore 15 174 0.3× 80 0.3× 262 1.0× 85 0.4× 43 0.4× 20 830
Tiphaine Bouriez‐Jones United Kingdom 10 31 0.1× 43 0.2× 166 0.6× 278 1.3× 38 0.3× 14 547
Lesley Everett United States 9 97 0.2× 43 0.2× 167 0.6× 43 0.2× 37 0.3× 39 478
Rodwell Mabaera United States 14 18 0.0× 299 1.1× 256 1.0× 391 1.8× 58 0.5× 20 827

Countries citing papers authored by Anna E. Koopmans

Since Specialization
Citations

This map shows the geographic impact of Anna E. Koopmans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna E. Koopmans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna E. Koopmans more than expected).

Fields of papers citing papers by Anna E. Koopmans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna E. Koopmans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna E. Koopmans. The network helps show where Anna E. Koopmans may publish in the future.

Co-authorship network of co-authors of Anna E. Koopmans

This figure shows the co-authorship network connecting the top 25 collaborators of Anna E. Koopmans. A scholar is included among the top collaborators of Anna E. Koopmans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna E. Koopmans. Anna E. Koopmans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Overdam, Koen A. van, Rogier A. Oldenburg, Anna E. Koopmans, et al.. (2020). Retinal haemangioblastomas in von Hippel–Lindau germline mutation carriers: progression, complications and treatment outcome. Acta Ophthalmologica. 98(5). 464–471. 10 indexed citations
2.
Yavuzyiğitoğlu, Serdar, Kyra N. Smit, Anna E. Koopmans, et al.. (2016). Correlation of Gene Mutation Status with Copy Number Profile in Uveal Melanoma. Ophthalmology. 124(4). 573–575. 24 indexed citations
3.
Yavuzyiğitoğlu, Serdar, Anna E. Koopmans, Robert M. Verdijk, et al.. (2016). Uveal Melanomas with SF3B1 Mutations. Ophthalmology. 123(5). 1118–1128. 190 indexed citations
4.
Nellist, Mark, Rutger W. W. Brouwer, Christel Kockx, et al.. (2015). Targeted Next Generation Sequencing reveals previously unidentified TSC1 and TSC2 mutations. BMC Medical Genetics. 16(1). 10–10. 58 indexed citations
5.
Beek, Jackelien G. M. van, Anna E. Koopmans, Jolanda Vaarwater, et al.. (2015). Metastatic disease in uveal melanoma. Melanoma Research. 25(5). 447–449. 6 indexed citations
6.
Brosens, Erwin, Yolande van Bever, Anna E. Koopmans, et al.. (2014). Clinical and etiological heterogeneity in patients with tracheo-esophageal malformations and associated anomalies. European Journal of Medical Genetics. 57(8). 440–452. 52 indexed citations
7.
Koopmans, Anna E., Robert M. Verdijk, Rutger W. W. Brouwer, et al.. (2014). Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma. Modern Pathology. 27(10). 1321–1330. 168 indexed citations
8.
Beek, Jackelien G. M. van, Anna E. Koopmans, Jolanda Vaarwater, et al.. (2014). The Prognostic Value of Extraocular Extension in Relation to Monosomy 3 and Gain of Chromosome 8q in Uveal Melanoma. Investigative Ophthalmology & Visual Science. 55(3). 1284–1284. 30 indexed citations
9.
Koopmans, Anna E., Hendrikus J. Dubbink, Dion Paridaens, et al.. (2014). Prevalence and Implications ofTERTPromoter Mutation in Uveal and Conjunctival Melanoma and in Benign and Premalignant Conjunctival Melanocytic Lesions. Investigative Ophthalmology & Visual Science. 55(9). 6024–6024. 66 indexed citations
10.
Koopmans, Anna E., Robert M. Verdijk, Thierry van den Bosch, et al.. (2013). BAP1 mutations in uveal melanoma. Investigative Ophthalmology & Visual Science. 54(15). 4223–4223. 2 indexed citations
11.
Koopmans, Anna E., et al.. (2013). Extraocular extension in uveal melanoma. Investigative Ophthalmology & Visual Science. 54(15). 4245–4245.
12.
Koopmans, Anna E., Annelies de Klein, Nicole C. Naus, & Emine Kılıç. (2013). Diagnosis and Management of Uveal Melanoma. European Ophthalmic Review. 7(1). 56–56. 3 indexed citations
13.
Koopmans, Anna E., et al.. (2013). Patient survival in uveal melanoma is not affected by oncogenic mutations in GNAQ and GNA11. British Journal of Cancer. 109(2). 493–496. 81 indexed citations
14.
Bosch, Thierry van den, et al.. (2013). Chemokine Receptor CCR7 Expression Predicts Poor Outcome in Uveal Melanoma and Relates to Liver Metastasis Whereas Expression of CXCR4 Is Not of Clinical Relevance. Investigative Ophthalmology & Visual Science. 54(12). 7354–7354. 32 indexed citations
15.
Veenemans, Jacobien, Paul Milligan, Andrew M. Prentice, et al.. (2011). Effect of Supplementation with Zinc and Other Micronutrients on Malaria in Tanzanian Children: A Randomised Trial. PLoS Medicine. 8(11). e1001125–e1001125. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026